< Back to companies

With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. In March 2021, the company received 510(k) clearance from the U.S. FDA for its revolutionary office-based MRI system, allowing practices and hospitals to seamlessly guide prostate interventions under the single-sided scanner.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2016
Website
www.promaxo.com/

Categories

Imaging DiagnosticsMedical ImagingDiagnosticsClinical Interventions
Only accessible to MedStartr community members. Join now

What do you think of Promaxo?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now